Design and development of paliperidone mesoporous silica template as a platform for surge dose drug delivery system

References

• Patil T, Sathe B, Jain P. Solubility enhancement of paliperidone by solid dispersion. IJUPLS. 2013;3:23–31.
   Google Scholar
• Patil SS, Misra RDK. The significance of macromolecular architecture in governing structure-property relationship for biomaterial applications: an overview. Mater Technol [Internet]. 2018;33(5):364–386.
   Web of Science ®Google Scholar
• Patil SS, Wadgaonkar PP. Temperature and pH dual stimuli responsive PCL- b -PNIPAAm block copolymer assemblies and the cargo release studies. J. Polym. Sci., Part A: Polym. Chem. 2017; 55(8): 1383–1396.
   Google Scholar
• Pandey A, Rath B, Dwivedi AK. Enhancement of dissolution rate and bioavailability of paliperidone by hot melt extrusion technique. J Sci Ind Res. 2014;73:680–685.
   Web of Science ®Google Scholar
• Kane J, Canas F, Kramer M. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schizophr Res. 2007;90:147–161.
   PubMed Web of Science ®Google Scholar
• Karlsson P, Dencker E, Nyberg S. Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects. Eur Neuropsycho Pharmacol. 2005;15:386.
   Web of Science ®Google Scholar
• Kumar VV, Kumara SS, Thriveench, et al. Enhancement of solubility and physicochemical characterization of paliperidone solid dispersions. JAPS. 2012;2:278–289.
   Google Scholar
• McCarthy CA, Ahern RJ, Dontireddy R, et al. Mesoporous silica formulation strategies for drug dissolution enhancement: a review. Expert Opin Drug Deliv. 2015;13(1):1–16.
   PubMed Web of Science ®Google Scholar
• Lashgari N, Badieia A, Mohammadi ZG. Modification of mesoporous silica SBA-15 with different organic molecules to gain chemical sensors: a review. Nano Chem Res. 2016;1:127–141.
   Google Scholar
• Rahmat N, Abdullah AZ, Mohamed AR. A review: mesoporous Santa Barbara Amorphous-15, types, synthesis and its applications towards biorefinery production. Am J Appl Sci. 2010;7:1579–1586.
   Google Scholar
• Speybroeck MV, Mellaerts R, RafMols et al. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. Eur J Pharm Sci. 2010;41:623–630.
   PubMed Web of Science ®Google Scholar
• Uejo F, Limwikrant W, Moribe K, et al. Dissolution improvement of fenofibrate by melting inclusion in mesoporous silica. Ajps. 2013;8:329–335.
   Google Scholar
• Zeid ZA, Othman AL. A review: fundamental aspects of silicate mesoporous materials. Materials. 2012;5:2874–2902.
   Web of Science ®Google Scholar
• Bharti C, Nagaich U, Pal AK, et al. Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig. 2015;5(3):124–133.
   PubMed Web of Science ®Google Scholar
• Jadhav KS, Dumbare PS, Pande VV. Mesoporous Silica Nanoparticles (MSN): A nanonetwork and hierarchical structure in drug delivery. J Nanomed Res. 2015;2(5):1–8.
   Google Scholar
• Bidhendi ME, NabiBidhendi GR, Mehrdadi N, et al. Modified Mesoporous Silica (SBA–15) with Trithiane as a new effective adsorbent for mercury ions removal from aqueous environment. J Environ Health Sci Eng. 2014;12(100):1–6.
   PubMedGoogle Scholar
• Panage S, Paned V, Patil S, et al. Design and synthesis of mesoporous silica for inclusion of poorly water soluble drug sertaconazole nitrate as a drug delivery platform. Der Pharmacia Lettre. 2014;6(4):159–168.
   Google Scholar
• Wang Y, Zhao Q, Hu Y, et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J of Nanomedicine. 2013;8:4015–4031.
   PubMed Web of Science ®Google Scholar
• Dange VU, Vibhute SK, Kendre PN, et al. Fabrication and characterization of hexagonal mesoporous silica (hms) for impregnating lornoxicam as a drug carrier. Austin Therapeutics. 2015;2(2):1022.
   Google Scholar
• Kumara S, Randhawa JK. Solid lipid nanoparticles of stearic acid for the drug delivery of Paliperidone. In: RSC Adv. 2015; 5 : 68743–68750.
   Google Scholar
• Pandey R, Dwivedi AK. Dissolution rate enhancement of BCS class II drug, paliperidone by spray drying. Rjpbcs. 2013;4(2):145–155.
   Google Scholar
• Ambrogi V, Perioli L, Pagano C, et al. Use of SBA-15 for furosemide oral delivery enhancement. Eur J Pharm Sci. 2012;46:43–48.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Trewyn BG, Slowing II, et al. Mesoporous silica nanoparticle-based double drug delivery system for glucose responsive controlled release of insulin and cyclic AMP. J AM Chem Soc. 2009;131:8398–8400.
   PubMed Web of Science ®Google Scholar
• Pandey A, Rath B, Dwivedi AK. Dissolution rate and bioavailability enhancement of co-ground mixtures of paliperidone, with different hydrophilic carriers. Int Curr Pharm J. 2013;2(3):70–77.
   Google Scholar
• Hassan AF, Sally A, Donia HA. MCM-41 for meloxicam dissolution improvement: in vitro release and in vivo bioavailability studies. J Braz Chem Soc. 2015;26:1367–1378.
   Web of Science ®Google Scholar
• Kotadiya RM, Patel VA, Patel HV. In vitro – in vivo evaluation of okra gum: guar gum compression coated diclofenac sodium tablets for colonic delivery: a factorial approach. Int J Pharm Bio Arch. 2012;3:228–236.
   Google Scholar
• Ahmed AB, Konwar R, Sengupta R. Atorvastatin calcium loaded chitosan nanoparticles: in vitro evaluation and in vivo pharmacokinetic studies in rabbits. Braz J Pharm Sci. 2015;51:467–477.
   Web of Science ®Google Scholar